净利润数值方面，共有106家上市公司预计2025年归属于上市公司股东的净利润下限超过1亿元，49家预 计超过3亿元，33家预计超过5亿元，13家预计超过10亿元。紫金矿业、药明康德、洛阳钼业、立讯精 密、盐湖股份等公司预计2025年归属于上市公司股东的净利润数值居前。 A股上市公司业绩预告加速披露。Wind数据显示，截至1月23日16时，A股共有710家上市公司对外披露 2025年全年业绩预告，284家预喜，预喜比例为40%。从报喜的上市公司所在行业角度看，有色金属、 半导体、生物医药、硬件设备、化工、汽车与零配件等行业表现亮眼。 近70家企业净利同比增逾100% 已披露2025年全年业绩预告的710家上市公司中，略增43家，扭亏57家，续盈4家，预增180家，已披露 业绩预告的上市公司总体较为分化。 净利润增长幅度方面，剔除扭亏影响，共有295家上市公司预计2025年归属于上市公司股东的净利润同 比增长幅度下限超过10%，237家预计超过30%，183家预计超过50%，67家预计超过100%，南方精工、 上海谊众、金安国纪、深南电A、利民股份、上汽集团等公司预计2025年归属于上市公司股东的净利润 同比增幅 ...

"十四五"收官之年，本市高精尖产业发展稳中有进。2025年，本市工业和信息软件业合计实现增加值突 破1.8万亿元，占全市GDP比重达到35.2%，对全市经济增长的贡献率接近六成。 1月22日，记者从市经信局举行的推动高精尖产业促升级、提质效、谋发展新闻发布会上获悉，市经信 局今年将发布不少于25个政策支持方向，计划投入资金支持超15亿元，全力推动高精尖产业发展"开好 头、快起步"。 15亿元资金支持投向高精尖产业 市经信局副局长刘维亮介绍，2025年，本市规模以上高技术制造业和战略性新兴产业增加值分别增长 7.5%和15.5%，工业和信息软件业在京新设企业数量同比分别增长19.4%和47.7%，首都产业结构高端化 态势显著。 下一步，市经信局将按照不超过总投入的30%、最高5000万元的标准予以补助，支持建设单位快速形成 中试能力。预计2026年率先建成20家重大中试载体，实现对主要产业领域、主要产业大区的基本覆盖； 2027年，再新建5至10家中试载体，实现对高精尖产业的全覆盖；2028年，以中试牵引成果快速转化的 能力全面建成。 北京持续打造全球人工智能产业创新高地，智能算力需求也将持续增长。据市经信局数 ...

Core Insights - A-share listed companies are accelerating the disclosure of performance forecasts for 2025, with 710 companies having reported, of which 284 are optimistic, resulting in a positive forecast ratio of 40% [1] Group 1: Performance Forecasts - Among the 710 companies that disclosed forecasts, 43 expect slight increases, 57 have turned losses into profits, 4 will maintain profitability, and 180 anticipate profit growth [2] - 295 companies expect a net profit growth of over 10%, with 237 expecting over 30%, 183 over 50%, and 67 over 100% [2] - Notable companies with high expected net profit growth include Southern Precision, Shanghai Yizhong, and SAIC Motor, with Southern Precision projecting a net profit of 300 million to 370 million yuan, representing a year-on-year increase of 1130% to 1417% [2] Group 2: Industry Performance - The industries showing strong performance include non-ferrous metals, biomedicine, semiconductors, hardware equipment, chemicals, and automotive parts [4] - In the non-ferrous metals sector, companies like Xianglu Tungsten, Zijin Mining, and Northern Rare Earth are performing well due to rising product prices and improved downstream demand [4] - Xianglu Tungsten expects a net profit of 12.5 million to 18 million yuan, significantly turning losses into profits, supported by rising tungsten prices and improved market conditions [4] Group 3: Specific Company Insights - WuXi AppTec anticipates a revenue of approximately 45.456 billion yuan, a year-on-year increase of about 15.84%, and a net profit of around 19.15 billion yuan, reflecting a growth of approximately 102.65% [3] - Zhongke Blue News expects a revenue of 1.83 billion to 1.85 billion yuan, with a net profit growth of 366.51% to 376.51% [5] - Shanghai Yizhong forecasts a net profit of 60 million to 70 million yuan, a year-on-year increase of 760.18% to 903.54%, driven by the inclusion of its core product in the national medical insurance directory [6] Group 4: Underperforming Industries - The real estate, textile and apparel, and photovoltaic industries are facing performance pressures, with only one out of 31 real estate companies reporting profits [7] - In the photovoltaic sector, companies like Tongwei Co., TCL Zhonghuan, and Trina Solar are expected to incur losses due to rising costs of key raw materials [7] - Retail companies are experiencing significant performance divergence, with many optimizing store layouts and closing unprofitable locations to enhance overall profitability [7]

（来源：千龙网） "十四五"收官之年，北京市高精尖产业发展稳中有进。2025年，北京市工业和信息软件业合计实现增加 值突破1.8万亿元，占全市GDP比重达到35.2%，对全市经济增长的贡献率接近六成。 1月22日，记者从市经信局举行的推动高精尖产业促升级、提质效、谋发展新闻发布会上获悉，市经信 局今年将发布不少于25个政策支持方向，计划投入资金支持超15亿元，全力推动高精尖产业发展"开好 头、快起步"。 市经信局副局长刘维亮介绍，2025年，本市规模以上高技术制造业和战略性新兴产业增加值分别增长 7.5%和15.5%，工业和信息软件业在京新设企业数量同比分别增长19.4%和47.7%，首都产业结构高端化 态势显著。 围绕高精尖产业领域年度重点任务，市经信局编制了2026年第一批高精尖产业发展项目资金和支持中小 企业发展资金实施指南，重点从"促创新""快转化""提质效""育成长"四个方面，拟发布不少于25个政策 支持方向，计划投入资金超15亿元，支持领域涵盖集成电路、生物医药、材料能源、信息软件、数字经 济等10余个重点产业。 创新发展过程中，许多企业面临创新研发路径不清晰、成果转化落地难等痛点问题。为此，实施 ...

A股上市公司业绩预告加速披露。Wind数据显示，截至1月23日16时，A股共有710家上市公司对外披露 2025年全年业绩预告，284家预喜，预喜比例为40%。从报喜的上市公司所在行业角度看，有色金属、 半导体、生物医药、硬件设备、化工、汽车与零配件等行业表现亮眼。 ● 本报记者 董添 近70家企业净利同比增逾100% 南方精工预计2025年全年实现归属于上市公司股东的净利润为3亿元至3.7亿元，同比增长1130%至 1417%。报告期内，公司归属于上市公司股东的净利润增长，主要源于公司对持有的江苏泛亚微透科技 股份有限公司等投资项目进行了公允价值评估，产生的公允价值变动收益在本报告期对公司税前利润的 影响金额预计为3亿元至3.2亿元之间，该公允价值变动收益属于非经常性损益。 净利润数值方面，共有106家上市公司预计2025年归属于上市公司股东的净利润下限超过1亿元，49家预 计超过3亿元，33家预计超过5亿元，13家预计超过10亿元。紫金矿业、药明康德、洛阳钼业、立讯精 密、盐湖股份等公司预计2025年归属于上市公司股东的净利润数值居前。 药明康德预计2025年全年实现营业收入约为454.56亿元，同比增长 ...

企业名称江苏皓博生物医药有限公司法定代表人肖立皓注册资本20000万人民币国标行业科学研究和技 术服务业>科技推广和应用服务业>技术推广服务地址常州西太湖科技产业园长扬路9号F3栋3楼企业类 型有限责任公司(自然人投资或控股的法人独资)营业期限2026-1-23至无固定期限登记机关常州市武进区 政务服务管理办公室 来源：市场资讯 序号股东名称持股比例1江苏康缘药业股份有限公司100% 经营范围含许可项目：药品生产；药品批发（依法须经批准的项目，经相关部门批准后方可开展经营活 动，具体经营项目以审批结果为准）技术服务、技术开发、技术咨询、技术交流、技术转让、技术推 广；信息技术咨询服务；信息咨询服务（不含许可类信息咨询服务）；市场营销策划；咨询策划服务； 企业管理咨询（除依法须经批准的项目外，凭营业执照依法自主开展经营活动） 天眼查显示，近日，江苏皓博生物医药有限公司成立，法定代表人为肖立皓，注册资本20000万人民 币，由江苏康缘药业股份有限公司全资持股。 ...

Core Viewpoint - The release of the "Management Measures for National Emerging Industry Innovation Centers" signifies a strategic move by the government to enhance the integration of innovation, industry, and finance, thereby addressing the disconnect between the innovation chain and the funding chain [3]. Group 1: Management Measures - The National Development and Reform Commission (NDRC) has published the "Management Measures," which outlines the establishment and operational guidelines for National Emerging Industry Innovation Centers [2]. - These innovation centers are positioned as platforms for technological innovation, aimed at nurturing future industries and enhancing new productive forces [1]. - The centers are expected to focus on major strategic industry development needs, led by industry leaders in collaboration with upstream and downstream partners, as well as academic institutions [1]. Group 2: Key Tasks and Funding Mechanisms - The "Management Measures" delineate eight primary tasks for the innovation centers, emphasizing the need to address national strategic demands and promote self-reliance in key technologies [1]. - A stable R&D investment mechanism is mandated to ensure continuous funding for technological innovation activities [2]. - The establishment of investment funds by the innovation centers is encouraged to support innovation, entrepreneurship, and the transformation of research outcomes into practical applications [2]. Group 3: Role of National Venture Capital Guidance Fund - The National Venture Capital Guidance Fund is highlighted as a crucial element in supporting the establishment and operation of innovation centers, facilitating the incubation and transformation of technological achievements [2]. - Three regional funds have been established under this guidance fund, focusing on sectors such as integrated circuits, quantum technology, biomedicine, brain-computer interfaces, and aerospace [2].

Core Viewpoint - The release of the "Management Measures for National Emerging Industry Innovation Centers" signifies a strategic move by the government to enhance the integration of innovation, industry, and finance, establishing a framework for the development of innovation centers that focus on key technological advancements and industry growth [3]. Group 1: Overview of the Management Measures - The National Emerging Industry Innovation Centers are positioned as platforms for technological innovation, aimed at nurturing future industries and enhancing new productive forces [1]. - The management measures emphasize collaboration among leading enterprises, industry supply chains, and academic institutions to develop critical technologies and foster a collaborative innovation ecosystem [1]. Group 2: Key Tasks and Objectives - The management measures outline eight primary tasks for the innovation centers, focusing on addressing national strategic needs and promoting self-reliance in high-level technology [1]. - Key objectives include the development and verification of critical processes, equipment, and materials, as well as accelerating the validation and iterative upgrade of independent innovation outcomes [1]. Group 3: Funding and Support Mechanisms - The management measures require the establishment of stable R&D funding mechanisms to support ongoing technological innovation activities [2]. - Innovation centers are encouraged to set up investment funds to facilitate innovation and the conversion of research outcomes into practical applications [2]. Group 4: Role of National Venture Capital - The National Venture Capital Guidance Fund is highlighted as a crucial element in supporting the incubation and transformation of technological achievements within the innovation centers [2]. - Three regional venture capital funds have been established, focusing on sectors such as integrated circuits, quantum technology, biomedicine, brain-computer interfaces, and aerospace [2].

（来源：经济参考报） 2026年，中国金融资本市场再度成为全球目光的焦点。近日，多家外资机构密集发布最新投资展望报 告，对中国市场投下"信任票"，指出中国资产具备显著的长期配置价值。 多位接受《经济参考报》记者采访的外资机构人士表示，以AI（人工智能）、半导体、生物医药等为 代表的科技板块具备较强吸引力。另外，消费板块，尤其是新消费领域也孕育更多投资机会。 多因素带动 中国资产受青睐 在外资机构人士看来，2026年，以A股和港股为代表的中国资产在国际市场的吸引力将进一步提升。 长期向好的经济基本面和稳定的政策环境为国内金融资本市场向好奠定基础。汇丰私人银行及财富管理 中国首席投资总监匡正表示，展望2026年，中国金融资本市场将在宏观再平衡与政策支持下，呈现结构 性回暖与调整并存的趋势，市场情绪有望持续改善。在他看来，一方面，固定资产投资在政府资金与新 项目支持下有望反弹，夯实增长基础并利好相关产业链；另一方面，科技创新领域的企业盈利前景持续 上调，市场的投资主线将紧扣"十五五"规划建议，人工智能、高端制造等战略性新兴产业将吸引资本持 续流入。 匡正认为，中国科技整体的含金量和估值跃升具备中长期的发展趋势。中国 ...

净利润增幅方面，剔除扭亏影响，共有373家上市公司预计2025年归属于上市公司股东的净利润同比增 长幅度下限超过10%，78家预计超过100%，南方精工、新强联、上海谊众、金安国纪、深南电A、利民 股份、上汽集团等公司预计2025年归属于上市公司股东的净利润同比增幅居前。 新强联1月23日晚公告称，公司预计2025年度归属于上市公司股东的净利润为7.80亿元—9.20亿元，同比 增长1093.07%—1307.21%。公司称，受益于风电行业需求回暖，装机需求持续释放，公司依托技术优 势进一步扩大了市场份额。在产能利用率保持较高水平的背景下，公司通过优化成本管控、提升高附加 值产品比重，实现了产品毛利率的稳步提高。 净利润金额方面，共有287家上市公司预计2025年归属于上市公司股东的净利润下限超过1亿元，68家预 计超过10亿元。紫金矿业、药明康德、洛阳钼业、立讯精密、盐湖股份等公司预计2025年归属于上市公 司股东的净利润居前。 1月23日晚，多家行业头部公司发布2025年全年业绩预告。 半导体设备龙头中微公司1月23日晚公告称，公司预计2025年全年实现营业收入约123.85亿元，同比增 长约36.62% ...